CYP27A1

From Wikipedia, the free encyclopedia
Jump to: navigation, search
CYP27A1
Available structures
PDB Ortholog search: PDBe RCSB
Identifiers
Aliases CYP27A1, CP27, CTX, CYP27, cytochrome P450 family 27 subfamily A member 1
External IDs OMIM: 606530 MGI: 88594 HomoloGene: 36040 GeneCards: 1593
RNA expression pattern
PBB GE CYP27A1 203979 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000784

NM_024264

RefSeq (protein)

NP_000775.1

NP_077226.2

Location (UCSC) Chr 2: 218.78 – 218.82 Mb Chr 1: 74.71 – 74.74 Mb
PubMed search [1] [2]
Wikidata
View/Edit Human View/Edit Mouse

CYP27A1 is a gene encoding a cytochrome P450 oxidase, and is commonly known as sterol 27-hydroxylase. This enzyme is located in many different tissues where it is found within the mitochondria. It is most prominently involved in the biosynthesis of bile acids.

Function[edit]

CYP27A1 participates in the degradation of cholesterol to bile acids in both the classic and acidic pathways.[1] It is the initiating enzyme in the acidic pathway to bile acids, yielding oxysterols by introducing a hydroxyl group to the carbon at the 27 position in cholesterol. In the acidic pathway, it produces 27-hydroxycholesterol from cholesterol whereas in the classic or neutral pathway, it produces 3β-hydroxy-5-cholestenoic acid.

It is also involved in the metabolism of vitamin D3.[2]

While CYP27A1 is present in many different tissues, its function in these tissues is largely uncharacterized. In macrophages, 27-hydroxycholesterol generated by this enzyme may be helpful against the production of inflammatory factors associated with cardiovascular disease.[3]

Clinical significance[edit]

Mutations in CYP27A1 are associated with cerebrotendineous xanthomatosis, a rare lipid storage disease.

Inhibitors of CYP27A1 may be effective as adjuvants in the treatment of ER-positive breast cancer due to inhibition of the production of 27-hydroxycholesterol (which has estrogenic actions and stimulates the growth of ER-positive breast cancer cells).[4] Some marketed drugs that have been identified as CYP27A1 inhibitors include anastrozole, fadrozole, bicalutamide, dexmedetomidine, ravuconazole, and posaconazole.[4]

Interactive pathway map[edit]

Click on genes, proteins and metabolites below to link to respective articles. [§ 1]

[[File:
VitaminDSynthesis_WP1531 Go to article Go to article Go to article Go to article go to article Go to article Go to article Go to article go to article go to article go to article go to article Go to article Go to article go to article Go to article go to article go to article go to article Go to article go to article
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
VitaminDSynthesis_WP1531 Go to article Go to article Go to article Go to article go to article Go to article Go to article Go to article go to article go to article go to article go to article Go to article Go to article go to article Go to article go to article go to article go to article Go to article go to article
|{{{bSize}}}px|alt=Vitamin D Synthesis Pathway edit]]
Vitamin D Synthesis Pathway edit
  1. ^ The interactive pathway map can be edited at WikiPathways: "VitaminDSynthesis_WP1531". 

References[edit]

  1. ^ Chiang JY (Feb 1998). "Regulation of bile acid synthesis". Frontiers in Bioscience 3: d176–93. PMID 9450986. 
  2. ^ Sakaki T, Kagawa N, Yamamoto K, Inouye K (Jan 2005). "Metabolism of vitamin D3 by cytochromes P450". Frontiers in Bioscience 10: 119–34. doi:10.2741/1514. PMID 15574355. 
  3. ^ Taylor JM, Borthwick F, Bartholomew C, Graham A (Jun 2010). "Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI". Cardiovascular Research 86 (3): 526–34. doi:10.1093/cvr/cvq015. PMID 20083572. 
  4. ^ a b Mast N, Lin JB, Pikuleva IA (Sep 2015). "Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant Therapy". Molecular Pharmacology 88 (3): 428–36. doi:10.1124/mol.115.099598. PMID 26082378. 

Further reading[edit]

  • Cali JJ, Russell DW (Apr 1991). "Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis". The Journal of Biological Chemistry 266 (12): 7774–8. PMID 1708392. 
  • Cali JJ, Hsieh CL, Francke U, Russell DW (Apr 1991). "Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis". The Journal of Biological Chemistry 266 (12): 7779–83. PMID 2019602. 
  • Guo YD, Strugnell S, Back DW, Jones G (Sep 1993). "Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions". Proceedings of the National Academy of Sciences of the United States of America 90 (18): 8668–72. doi:10.1073/pnas.90.18.8668. PMC 47419. PMID 7690968. 
  • Kim KS, Kubota S, Kuriyama M, Fujiyama J, Björkhem I, Eggertsen G, Seyama Y (Jun 1994). "Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX)". Journal of Lipid Research 35 (6): 1031–9. PMID 7915755. 
  • Maruyama K, Sugano S (Jan 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene 138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298. 
  • Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, Berkman N, Cali JJ, Klapholz L, Berginer VM (Jun 1993). "Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin". The Journal of Clinical Investigation 91 (6): 2488–96. doi:10.1172/JCI116484. PMC 443309. PMID 8514861. 
  • Chen W, Kubota S, Kim KS, Cheng J, Kuriyama M, Eggertsen G, Björkhem I, Seyama Y (May 1997). "Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families". Journal of Lipid Research 38 (5): 870–9. PMID 9186905. 
  • Reiss AB, Martin KO, Rojer DE, Iyer S, Grossi EA, Galloway AC, Javitt NB (Jun 1997). "Sterol 27-hydroxylase: expression in human arterial endothelium". Journal of Lipid Research 38 (6): 1254–60. PMID 9215552. 
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (Oct 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149. 
  • Chen W, Kubota S, Ujike H, Ishihara T, Seyama Y (Oct 1998). "A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): its effects on pre-mRNA splicing and enzyme activity". Biochemistry 37 (43): 15050–6. doi:10.1021/bi9807660. PMID 9790667. 
  • Shiga K, Fukuyama R, Kimura S, Nakajima K, Fushiki S (Nov 1999). "Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis". Journal of Neurology, Neurosurgery, and Psychiatry 67 (5): 675–7. doi:10.1136/jnnp.67.5.675. PMC 1736608. PMID 10519880. 
  • Gascon-Barré M, Demers C, Ghrab O, Theodoropoulos C, Lapointe R, Jones G, Valiquette L, Ménard D (Jan 2001). "Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney". Clinical Endocrinology 54 (1): 107–15. doi:10.1046/j.1365-2265.2001.01160.x. PMID 11167933. 
  • Johnston TP, Nguyen LB, Chu WA, Shefer S (Oct 2001). "Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis". International Journal of Pharmaceutics 229 (1-2): 75–86. doi:10.1016/S0378-5173(01)00834-1. PMID 11604260. 
  • Toba H, Fukuyama R, Sasaki M, Shiga K, Ishibashi S, Fushiki S (Jan 2002). "A Japanese patient with cerebrotendinous xanthomatosis has different mutations within two functional domains of CYP27". Clinical Genetics 61 (1): 77–8. doi:10.1034/j.1399-0004.2002.610116.x. PMID 11903362. 
  • Lamon-Fava S, Schaefer EJ, Garuti R, Salen G, Calandra S (Mar 2002). "Two novel mutations in the sterol 27-hydroxylase gene causing cerebrotendinous xanthomatosis". Clinical Genetics 61 (3): 185–91. doi:10.1034/j.1399-0004.2002.610303.x. PMID 12000359. 
  • Björkhem I, Araya Z, Rudling M, Angelin B, Einarsson C, Wikvall K (Jul 2002). "Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1". The Journal of Biological Chemistry 277 (30): 26804–7. doi:10.1074/jbc.M202343200. PMID 12011083. 
  • von Bahr S, Movin T, Papadogiannakis N, Pikuleva I, Rönnow P, Diczfalusy U, Björkhem I (Jul 2002). "Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1)". Arteriosclerosis, Thrombosis, and Vascular Biology 22 (7): 1129–35. doi:10.1161/01.ATV.0000022600.61391.A5. PMID 12117727. 
  • Meir K, Kitsberg D, Alkalay I, Szafer F, Rosen H, Shpitzen S, Avi LB, Staels B, Fievet C, Meiner V, Björkhem I, Leitersdorf E (Sep 2002). "Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis". The Journal of Biological Chemistry 277 (37): 34036–41. doi:10.1074/jbc.M201122200. PMID 12119285. 
  • Lee MJ, Huang YC, Sweeney MG, Wood NW, Reilly MM, Yip PK (Sep 2002). "Mutation of the sterol 27-hydroxylase gene ( CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis". Journal of Neurology 249 (9): 1311–2. doi:10.1007/s00415-002-0762-9. PMID 12242561. 

External links[edit]